This week, Sanofi US issued a voluntary nationwide recall of ALL Auvi-Q® epinephrine injectors.
These injectors, like other epinephrine injectors, are used to treat life-threatening allergic reactions (anaphylaxis).
Families of patients who currently use the Auvi-Q as their auto-injector should contact their physician immediately to arrange for a prescription to one of two alternate epinephrine auto-injectors (EpiPen or Adrenaclick). University of Michigan Food Allergy Clinic patients can contact us directly at 888-229-2409.
Why the recall? While the epinephrine itself is not the problem. The recall is related to the injector device itself, and possible inaccurate dosage delivery.
If a patient experiencing a serious allergic reaction did not receive the intended dose, the consequences could be life-threatening because anaphylaxis is a life‑threatening condition.
In the event of an allergic reaction prior to having received an alternate epinephrine auto-injector, patients should use their Auvi-Q device only if another auto-injector is unavailable, and then call 911 for emergency medical care.
For more information about the recall, as well as directions for returning your Auvi-Q and arranging for reimbursement for whichever type of auto-injector your physician recommends as a replacement for your Auvi-Q, visit the Auvi-Q website.
Take the next step:
University of Michigan C.S. Mott Children’s Hospital is consistently ranked one of the best hospitals in the country. It was nationally ranked in all ten pediatric specialties in U.S. News Media Group’s “America’s Best Children’s Hospitals,” and among the 10 best children’s hospitals in the nation by Parents Magazine. In December 2011, the hospital opened our new 12-story, state-of-the-art facility offering cutting-edge specialty services for newborns, children and women.